Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1986 May;23(5):929–933. doi: 10.1128/jcm.23.5.929-933.1986

Role of proteinase in the formation of inhibitory levels of hematin by group A streptococcus cultures on blood-containing media.

W L Hynes, J R Tagg
PMCID: PMC268752  PMID: 3519664

Abstract

Group A streptococci were tested for proteinase production and for the possible relationship of this production to the generation of bacteriocinlike inhibitor activity. Of 126 strains tested, 83% were positive for proteinase, and a similar distribution was found among strains isolated in association with rheumatic fever (89%) and nephritis (94%) and from uncomplicated acute infections (78%). Although application of an inhibitor production (P) typing scheme demonstrated a variety of P types, all of the proteinase-positive strains produced inhibitory activity and over 65% of these strains were P type 204. It was shown that hematin was responsible for this P type 204 activity and that it was produced only by actively proteolytic strains when grown on a hemoglobin-containing medium. Conditions optimizing proteinase production (anaerobic incubation at 37 degrees C on a test medium prepared from Columbia agar base [GIBCO Laboratories, Grand Island, N.Y.]) increased P type 204 activity. Interference with proteinase activity either by growth of the cultures at an alkaline pH or by incorporation of sub-growth inhibitory concentrations of either iodoacetic acid or lincomycin into the medium prevented production of P type 204 activity. Whether significant conversion of hemoglobin to hematin occurs in vivo and the possible implications of this conversion with regard to the pathogenesis of group A streptococcal infections remain to be determined.

Full text

PDF
929

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akao T., Akao T., Kobashi K., Lai C. Y. The role of protease in streptolysin S formation. Arch Biochem Biophys. 1983 Jun;223(2):556–561. doi: 10.1016/0003-9861(83)90620-3. [DOI] [PubMed] [Google Scholar]
  2. DEIBEL R. H. HYDROLYSIS OF PROTEINS AND NUCLEIC ACIDS BY LANCEFIELD GROUP A AND OTHER STREPTOCOCCI. J Bacteriol. 1963 Dec;86:1270–1274. doi: 10.1128/jb.86.6.1270-1274.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. ELLIOTT S. D. The crystallization and serological differentiation of a streptococcal proteinase and its precursor. J Exp Med. 1950 Sep;92(3):201–218. doi: 10.1084/jem.92.3.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. FOX E. N., STEVENSON D. Effects of trypsin on the permeability of streptococci. J Bacteriol. 1960 Oct;80:513–521. doi: 10.1128/jb.80.4.513-521.1960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gerlach D., Knöll H., Köhler W., Ozegowski J. H., Hríbalova V. Isolation and characterization of erythrogenic toxins. V. Communication: identity of erythrogenic toxin type B and streptococcal proteinase precursor. Zentralbl Bakteriol Mikrobiol Hyg A. 1983 Sep;255(2-3):221–233. [PubMed] [Google Scholar]
  6. Johnson D. W., Tagg J. R., Wannamaker L. W. Production of a bacteriocine-like substance by group-A streptococci of M-type 4 and T-pattern 4. J Med Microbiol. 1979 Nov;12(4):413–427. doi: 10.1099/00222615-12-4-413. [DOI] [PubMed] [Google Scholar]
  7. KELLNER A., ROBERTSON T. Myocardial necrosis produced in animals by means of crystalline streptococcal proteinase. J Exp Med. 1954 May 1;99(5):495–503. doi: 10.1084/jem.99.5.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Laughon B. E., Syed S. A., Loesche W. J. Rapid identification of Bacteroides gingivalis. J Clin Microbiol. 1982 Feb;15(2):345–346. doi: 10.1128/jcm.15.2.345-346.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Straus D. C., Mattingly S. J., Milligan T. W., Doran T. I., Nealon T. J. Protease production by clinical isolates of type III group B streptococci. J Clin Microbiol. 1980 Sep;12(3):421–423. doi: 10.1128/jcm.12.3.421-423.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Straus D. C. Protease production by Streptococcus sanguis associated with subacute bacterial endocarditis. Infect Immun. 1982 Dec;38(3):1037–1045. doi: 10.1128/iai.38.3.1037-1045.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Tagg J. R., Bannister L. V. "Fingerprinting" beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors. J Med Microbiol. 1979 Nov;12(4):397–411. doi: 10.1099/00222615-12-4-397. [DOI] [PubMed] [Google Scholar]
  12. Tagg J. R. Production of bacteriocin-like inhibitors by group A streptococci of nephritogenic M types. J Clin Microbiol. 1984 Jun;19(6):884–887. doi: 10.1128/jcm.19.6.884-887.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Tagg J. R., Wong H. K. Inhibitor production by group-G streptococci of human and of animal origin. J Med Microbiol. 1983 Nov;16(4):409–415. doi: 10.1099/00222615-16-4-409. [DOI] [PubMed] [Google Scholar]
  14. Takazoe I., Nakamura T., Okuda K. Colonization of the subgingival area by Bacteroides gingivalis. J Dent Res. 1984 Mar;63(3):422–426. doi: 10.1177/00220345840630031201. [DOI] [PubMed] [Google Scholar]
  15. Travis J., Salvesen G. S. Human plasma proteinase inhibitors. Annu Rev Biochem. 1983;52:655–709. doi: 10.1146/annurev.bi.52.070183.003255. [DOI] [PubMed] [Google Scholar]
  16. VAN HEYNINGEN W. E. The antibacterial activity of haematin. J Gen Microbiol. 1951 Oct;5(4):758–765. doi: 10.1099/00221287-5-4-758. [DOI] [PubMed] [Google Scholar]
  17. Varani J., Johnson K., Kaplan J. Development of a solid-phase assay for measurement of proteolytic enzyme activity. Anal Biochem. 1980 Sep 15;107(2):377–384. doi: 10.1016/0003-2697(80)90399-1. [DOI] [PubMed] [Google Scholar]
  18. WHITNEY D. M., ANIGSTEIN L., MICKS D. W. Antibacterial activity of hydrolyzed red blood cells in vitro. Proc Soc Exp Biol Med. 1950 Jun;74(2):346–350. doi: 10.3181/00379727-74-17902. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES